Niagen Bioscience Income Statement (2010-2026) | NAGE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	17.70M	17.31M	17.76M	17.26M	16.73M	17.06M	21.00M	22.56M	20.32M	19.50M	21.20M	22.15M	22.74M	25.58M	29.12M	30.48M	31.12M	33.99M	33.84M	31.47M
Cost of Revenue (Quarter)	6.89M	6.73M	6.89M	6.73M	6.69M	6.86M	8.98M	9.04M	7.97M	7.53M	8.26M	8.70M	2.12M	9.34M	10.93M	2.48M	2.56M	12.06M	3.84M	11.50M
Gross Profit (Quarter)	10.81M	10.58M	10.87M	10.53M	10.04M	10.21M	12.02M	13.52M	12.36M	11.97M	12.94M	13.46M	13.69M	16.24M	18.20M	19.33M	20.23M	21.93M	21.70M	19.98M
Operating items
Research & Development (Quarter)	1.00M	1.00M	25.57M	8.24M	1.25M	5.87M	24.77M	1.19M	1.36M	1.24M	22.64M	2.10M	1.32M	7.04M	8.72M	1.26M	1.57M	1.79M	1.71M	1.48M
Selling, General & Administrative (Quarter)	9.13M	11.20M	6.50M	8.95M	7.16M	6.18M	5.99M	6.42M	7.30M	5.84M	5.43M	5.35M	5.66M	6.30M	1.05M	5.18M	7.27M	7.13M	7.48M	7.24M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	6.23M	7.22M	-15.88M	1.08M	8.02M	1.22M	-17.30M	7.87M	6.01M	6.04M	-14.96M	6.74M	6.97M	1.29M	1.31M		8.21M	8.77M	8.43M	4.80M
Operating Expenses (Quarter)	16.36M	19.42M	16.18M	18.26M	16.43M	13.27M	13.46M	15.49M	14.67M	13.12M	13.11M	14.19M	13.95M	14.64M	11.09M	14.56M	17.04M	17.69M	17.62M	18.40M
Operating Income (Quarter)	-5.55M	-8.84M	-5.32M	-7.73M	-6.39M	-3.06M	-1.44M	-1.97M	-2.32M	-1.15M	-0.17M	-0.73M	-0.26M	1.60M	7.11M	4.77M	3.19M	4.24M	4.09M	1.58M
EBIT (Quarter)	-5.55M	-8.84M	-5.32M	-7.73M	-6.39M	-3.06M	-1.44M	-1.97M	-2.32M	-1.15M	-0.17M	-0.73M	-0.26M	1.60M	7.11M	4.77M	3.19M	4.24M	4.09M	1.58M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)									0.12M	0.19M	0.28M	0.24M	0.24M	0.28M	0.37M	0.46M	0.55M	0.56M	0.34M	0.38M
Net income details
EBT (Quarter)	-9.68M	-9.68M	-4.84M	-8.23M	-11.66M	-8.11M	-1.58M	-6.68M	-6.79M	-5.39M	-0.27M	-0.49M	-0.01M	1.88M	7.48M	5.23M	3.74M	4.80M	4.42M	6.74M
Tax Provisions (Quarter)															0.30M	0.17M	0.13M	0.22M	0.29M	0.42M
Profit After Tax (Quarter)	-5.57M	-8.86M	-5.33M	-7.74M	-6.40M	-0.98M	-1.42M	-1.90M	-2.19M	-0.96M	0.11M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.08M	6.32M
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-9.68M	-9.68M	-4.84M	-8.23M	-11.66M	-8.11M	-1.58M	-6.68M	-6.79M	-5.39M	-0.27M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.13M	6.32M
Consolidated Net Income (Quarter)	-9.68M	-9.68M	-4.84M	-8.23M	-11.66M	-8.11M	-1.58M	-6.68M	-6.79M	-5.39M	-0.27M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.13M	6.32M
Income towards Parent Company (Quarter)	-9.68M	-9.68M	-4.84M	-8.23M	-11.66M	-8.11M	-1.58M	-6.68M	-6.79M	-5.39M	-0.27M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.13M	6.32M
Net Income towards Common Stockholders (Quarter)	-9.68M	-9.68M	-4.84M	-8.23M	-11.66M	-8.11M	-1.58M	-6.68M	-6.79M	-5.39M	-0.27M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.13M	6.32M
Additional items
EPS (Basic) (Quarter)	-0.14	-0.14	-0.07	-0.12	-0.17	-0.12	-0.02	-0.09	-0.09	-0.07	0.00	-0.01	0.00	0.02	0.09	0.07	0.05	0.06	0.05	0.08
EPS (Diluted) (Quarter)	-0.14	-0.14	-0.07	-0.12	-0.17	-0.12	-0.02	-0.09	-0.09	-0.07	0.00	-0.01	0.00	0.02	0.09	0.06	0.04	0.05	0.05	0.07
Shares Outstanding (Quarter)	67.99M	68.24M	67.19M	68.31M	68.34M	68.34M	69.73M	74.80M	74.97M	75.05M	74.98M	75.23M	75.56M	75.97M	75.93M	77.81M	79.25M	79.78M	79.18M	79.92M
Shares Outstanding (Diluted) (Quarter)	67.99M	68.24M	67.19M	68.31M	68.34M	68.34M	69.73M	74.80M	74.97M	75.05M	74.98M	75.23M	75.56M	77.77M	78.12M	83.23M	86.24M	86.62M	85.44M	84.57M
Shares Outstanding (Entity) (Quarter)	68.01M	68.09M	68.13M	68.15M	68.16M	68.17M	74.57M	74.67M	74.86M	74.91M	74.98M	75.15M	75.47M	76.03M	77.33M	78.43M	79.59M	79.64M	79.71M	79.46M
EBITDA (Quarter)	-5.55M	-8.84M	-5.32M	-7.73M	-6.39M	-3.06M	-1.44M	-1.97M	-2.32M	-1.15M	-0.17M	-0.73M	-0.26M	1.60M	7.11M	4.77M	3.19M	4.24M	4.09M	1.58M
Interest Expenses (Quarter)	4.13M	0.84M	-0.47M	0.50M	5.27M	5.05M	0.14M	4.71M	4.48M	4.25M	0.10M	0.49M	0.25M	3.13M	0.24M	4.03M	3.89M	0.66M	-0.64M	0.42M
Tax Rate (Quarter)															4.08%	3.21%	3.43%	4.63%	6.60%	6.19%

Research Tools

Developers

Niagen Bioscience Income Statement (2010-2026) | NAGE

Research Tools

Developers

Niagen Bioscience Income Statement (2010-2026) | NAGE

Create an account

Sign In

Reset Password